Found: 4
Select item for more details and to access through your institution.
The Rheumatology Drugs for COVID-19 Management: Which and When?
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 4, p. 783, doi. 10.3390/jcm10040783
- By:
- Publication type:
- Article
Metabolic Syndrome and Its Components Have a Different Presentation and Impact as Cardiovascular Risk Factors in Psoriatic and Rheumatoid Arthritis.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 15, p. 5031, doi. 10.3390/jcm12155031
- By:
- Publication type:
- Article
Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory Study.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 957, doi. 10.3390/jcm12030957
- By:
- Publication type:
- Article
Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks.
- Published in:
- BioDrugs, 2020, v. 34, n. 4, p. 415, doi. 10.1007/s40259-020-00430-1
- By:
- Publication type:
- Article